These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 1271137)
1. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia. Hughes IA; Winter JS J Pediatr; 1976 May; 88(5):766-73. PubMed ID: 1271137 [TBL] [Abstract][Full Text] [Related]
2. The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia. Hughes IA; Winter JS J Clin Endocrinol Metab; 1978 Jan; 46(1):98-104. PubMed ID: 752027 [TBL] [Abstract][Full Text] [Related]
3. Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia. Lippe BM; LaFranchi SH; Lavin N; Parlow A; Coyotupa J; Kaplan SA J Pediatr; 1974 Dec; 85(6):782-7. PubMed ID: 4371221 [No Abstract] [Full Text] [Related]
4. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression. Lee PA; Urban MD; Gutai JP; Migeon CJ Horm Res; 1980; 13(6):347-57. PubMed ID: 7196877 [TBL] [Abstract][Full Text] [Related]
5. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules]. Cattani A; Mahaha D; Michaud P; Rodríguez JA; López JM; García H; Foradori A; Velásquez CG Rev Chil Pediatr; 1984; 55(6):374-9. PubMed ID: 6536989 [No Abstract] [Full Text] [Related]
7. Reinstitution of mineralocorticoid therapy in congenital adrenal hyperplasia. Effects on control and growth. Jansen M; Wit JM; van den Brande JL Acta Paediatr Scand; 1981 Mar; 70(2):229-33. PubMed ID: 7015786 [TBL] [Abstract][Full Text] [Related]
8. Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia. Hughes IA; Wilton A; Lole CA; Gray OP Arch Dis Child; 1979 May; 54(5):350-5. PubMed ID: 475410 [TBL] [Abstract][Full Text] [Related]
10. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements. Hughes IA; Read GF Horm Res; 1984; 19(2):77-85. PubMed ID: 6538545 [TBL] [Abstract][Full Text] [Related]
11. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia. Frisch H; Parth K; Schober E; Swoboda W Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759 [TBL] [Abstract][Full Text] [Related]
12. [17-hydroxyprogesterone in the diagnosis and treatment of adrenogenital syndrome]. Cassorla F Rev Chil Pediatr; 1982; 53(4):295-304. PubMed ID: 7163538 [No Abstract] [Full Text] [Related]
13. Urinary excretion of 17-hydroxypregnanolones in patients with different forms of congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. Homoki J; Sólyom J; Wachter U; Teller WM Eur J Pediatr; 1992 Jan; 151(1):24-8. PubMed ID: 1728539 [TBL] [Abstract][Full Text] [Related]
14. 17-Hydroxyprogesterone in normal children and congenital adrenal hyperplasia. Measurement in serum by radioimmunoassay after thin-layer chromatography. Petersen KE; Christensen T Acta Paediatr Scand; 1979 Mar; 68(2):205-11. PubMed ID: 217232 [TBL] [Abstract][Full Text] [Related]
15. A study of the renin-aldosterone system in congenital adrenal hyperplasia. Strickland AL; Kotchen TA J Pediatr; 1972 Nov; 81(5):962-9. PubMed ID: 5086723 [No Abstract] [Full Text] [Related]